Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowNayax to Report 2026 Q1 Earnings on May 12, 2026
27m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Jaguar Animal Health Inc logo

Jaguar Animal Health Inc

About

Jaguar Animal Health Inc (NASDAQ:JAGX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 24 2026
Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Apr 20 2026
Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Apr 8 2026
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Apr 7 2026
Jaguar Health Reports 2025 Financials
Apr 2 2026
Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress

Financials

Revenue
$11.79 M
Market Cap
$4.97 M
EPS
-2.58

Community Chat

Ask AI

6ix6ixAIEvents